Literature DB >> 10228107

Airway inflammation, exhaled nitric oxide, and severity of asthma in patients with western red cedar asthma.

M Chan-Yeung1, H Obata, M Dittrick, H Chan, R Abboud.   

Abstract

Examination of induced sputum and measurement of exhaled NO have been advocated as noninvasive methods of assessing the degree of airway inflammation. In this study, we performed follow-up evaluation on 71 subjects with asthma caused by exposure to Western red cedar; 50 subjects had left exposure, whereas the rest continued to work in the same job. Spirometry, methacholine challenge tests, exhaled nitric oxide, and sputum induction were carried out. Of the 50 subjects who left exposure, 12 had no respiratory impairment according to the American Throacic Society guidelines for assessing respiratory impairment in patients with asthma, 17 belonged to Class 1, 12 to Class 2, five to Class 3, and four to Class 4. The percentage of eosinophils in induced sputum showed a significant inverse relationship with FEV1 (r = -0.46, p < 0.001), and a significant positive correlation with levels of exhaled NO (r = 0.42, p < 0.001) and with the class of respiratory impairment (r = 0.52, p < 0.001). Mean percent eosinophils were 1.5 for impairment Class 0, 2.2 for Class 1, 1.7 for Class 2, 6.8 for Class 3, and 16.3 for Class 4. No relationship was found between the levels of exhaled NO and the functional parameters as well as the impairment class. NO levels in ppb were 21 for impairment Class 0, 30 for Class 1, 22 for Class 2, 26 for Class 3, and 49 for Class 4. This study also provides objective evidence that airway inflammation, as indicated by induced sputum, corroborates the rating of respiratory impairment in patients with asthma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10228107     DOI: 10.1164/ajrccm.159.5.9807007

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  6 in total

1.  Changes in exhaled nitric oxide levels after bronchial allergen challenge.

Authors:  María Pedrosa; Pilar Barranco; Valentín López-Carrasco; Santiago Quirce
Journal:  Lung       Date:  2012-01-07       Impact factor: 2.584

Review 2.  Asthma in the workplace: a Canadian contribution and perspective.

Authors:  Jean-Luc Malo; Moira Chan-Yeung
Journal:  Can Respir J       Date:  2007-10       Impact factor: 2.409

3.  Occupational asthma due to low molecular weight agents: eosinophilic and non-eosinophilic variants.

Authors:  W Anees; V Huggins; I D Pavord; A S Robertson; P S Burge
Journal:  Thorax       Date:  2002-03       Impact factor: 9.139

4.  Asthma morbidity among inner-city adolescents receiving guidelines-based therapy: role of predictors in the setting of high adherence.

Authors:  Rebecca S Gruchalla; Hugh A Sampson; Elizabeth Matsui; Gloria David; Peter J Gergen; Agustin Calatroni; Mark Brown; Andrew H Liu; Gordon R Bloomberg; James F Chmiel; Rajesh Kumar; Carin Lamm; Ernestine Smartt; Christine A Sorkness; Suzanne F Steinbach; Kelly D Stone; Stanley J Szefler; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2009-07-16       Impact factor: 10.793

5.  Airway hyperresponsiveness and quality of life in Western red cedar asthmatics removed from exposure.

Authors:  Jian-Qing He; Moira Chan-Yeung; Chris Carlsten
Journal:  PLoS One       Date:  2012-12-04       Impact factor: 3.240

6.  Respiratory impairment and systemic inflammation in cedar asthmatics removed from exposure.

Authors:  Chris Carlsten; Anne Dybuncio; Mandy M Pui; Moira Chan-Yeung
Journal:  PLoS One       Date:  2013-02-27       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.